These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3929599)

  • 1. Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.
    Owens DR
    Am J Med; 1985 Aug; 79(2B):27-32. PubMed ID: 3929599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 4. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD; Zeidler A; Kumar D
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sulfonylureas for the treatment of type II diabetes: an update.
    Shank WA; Morrison AD
    South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
    Balabolkin MI; Nedosugova LV
    Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH; Lowy C; Perkins JR; Lim HS
    Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
    Tatoń J; Koliński P
    Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment strategies for patients with non-insulin-dependent diabetes mellitus.
    Boden G
    Am J Med; 1985 Aug; 79(2B):23-6. PubMed ID: 2994471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
    Holman RR
    Metabolism; 2006 May; 55(5 Suppl 1):S2-5. PubMed ID: 16631806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview.
    Melander A
    Diabetes; 2004 Dec; 53 Suppl 3():S151-5. PubMed ID: 15561903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus.
    Kolterman OG
    Am J Med; 1985 Sep; 79(3B):23-33. PubMed ID: 3931459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
    Waldhäusl W
    Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathogenesis of non-insulin-dependent diabetes: an update.
    DeFronzo RA; Ferrannini E
    Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfonylureas in the treatment of diabetes mellitus--1985.
    Gerich JE
    Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of sulfonylureas in the therapy for type 2 diabetes mellitus.
    Del Prato S; Pulizzi N
    Metabolism; 2006 May; 55(5 Suppl 1):S20-7. PubMed ID: 16631807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.